JPRN-jRCTs071180008已完成4 期
Study of evaluating shortening of a hospitalization period after salvage therapy in patients with relapsed or refractory malignant lymphoma - Evaluation of post-salvage therapy hospitalization period in patients with malignant lymphoma
Iwasaki Hiromi0 个研究点目标入组 16 人开始时间: 2018年11月27日最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 16
研究概览
简要总结
The study data indicated that treatment with pegfilgrastim allowed management of patients receiving salvage therapy as outpatients. Given that there was no case of hospitalization due to FN during outpatient management and that no clinically significant safety concern was noted, outpatient management after salvage therapy seems acceptable.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •1)Relapsed or refractory non-hodgkins lymphoma and hodgkins lymphoma
- •2)Age >= 20 years old at informed consent
- •3)ECOG PS <= 2
- •4)Patients who are going to receive (R)EPOCH, CHASE(R), (R)DeVIC or (R)ESHAP regimen.
- •5)Patients who meet the following criteria within 14 days
- •before salvage therapy.
- •Neutrophil count >= 1,000/ul
- •Platelet >= 50,000/ul
- •Total bilirubin level <= 2 times the upper normal limit in institute
- •Serum creatinine <= 1.5mg/dl
- •6) Patients who can immediately go to hospital when the
- •condition changed suddenly.
- •7) Given written informed consent
排除标准
- •1)Patients who have a possibility of severe infection after the entry or active infection at the entry.
- •2)Pregnant or breast-feeding females and females who have a possibility of pregnancy.
- •3)Patients who have any other inadequacy for this study by physicians.
研究者
相似试验
已完成
2 期
Pegfilgrastim Administered on the Same Day as Chemotherapy in Non-Hodgkin's LymphomaNon-Hodgkin's LymphomaNCT00115193Amgen77
已完成
2 期
Trial Comparing Pegfilgrastim With Filgrastim as an Adjunct to Chemotherapy for Acute Myeloid Leukaemia (AML)Myeloid LeukemiaNCT00114764Amgen84
已完成
2 期
Same Day Dosing of Pegfilgrastim in Breast Cancer Patients Undergoing Chemotherapy (TAC)FeverNeutropeniaBreast CancerNCT00115414Amgen
已完成
4 期
An Expanded Access Program of Pegfilgrastim (Neulastim) in Participants With Non-Hodgkin's Lymphoma (NHL)Non-Hodgkin's LymphomaNCT02782845Hoffmann-La Roche53
已完成
2 期
Evaluating Pegfilgrastim and a Multi-Day Topotecan Regimen in Subjects With Relapsed or Refractory Ovarian CancerOvarian CancerNCT00113789Amgen21